0001104659-14-025625.txt : 20140403
0001104659-14-025625.hdr.sgml : 20140403
20140403163205
ACCESSION NUMBER: 0001104659-14-025625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140401
FILED AS OF DATE: 20140403
DATE AS OF CHANGE: 20140403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PATEL SAMIR CHANDRAKANT
CENTRAL INDEX KEY: 0001277966
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 14742595
MAIL ADDRESS:
STREET 1: 3 TIMES SQUARE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
a4.xml
4
X0306
4
2014-04-01
0
0001410939
Ophthotech Corp.
OPHT
0001277966
PATEL SAMIR CHANDRAKANT
C/O OPHTHOTECH CORPORATION
ONE PENN PLAZA, 19TH FLOOR
NEW YORK
NY
10119
1
1
0
0
President
Common Stock
2014-04-01
4
S
0
10676
33.98
D
124991
D
Common Stock
2014-04-01
4
S
0
6100
34.76
D
118891
D
Common Stock
2014-04-01
4
S
0
100
35.70
D
118791
D
The sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Representing Person on December 16, 2013.
These shares were disposed of in multiple transactions on April 1, 2014 at actual sales prices ranging from $33.50 to $34.45 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares were disposed of in multiple transactions on April 1, 2014 at actual sales prices ranging from $34.51 to $35.41 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Tom Biancardi, as Attorney-in-Fact for Samir Patel
2014-04-03